Oramed Pharmaceuticals Inc. (ORMP): Cost of Revenue
Partial revenue. In this company's filings, net income for the year ended 2025-12-31 is larger than reported revenue. The revenue it tags covers only part of its income (banks and REITs often tag only fee income this way, leaving out interest or rent), so it is not the company's whole top line. Margins on it are not computed, and it is left out of revenue rankings.
$1.99M
Year ended 2025-12-31
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.99M | n/a | 2026-03-26, From 2025-01-01 |
| No annual figure between 2019-08-31 and 2025-12-31. | |||
| 2019-08-31 | $90.0K | n/m | 2020-11-24, From 2018-09-01 |
| 2018-08-31 | -$86.0K | n/m | 2019-11-27, From 2017-09-01 |
| 2017-08-31 | $187.0K | -61.8% | 2019-11-27, From 2016-09-01 |
| 2016-08-31 | $490.0K | n/a | 2017-11-29, From 2015-09-01 |